Cormorant Asset Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Cormorant Asset Management’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,667	Closed	-$6.54M	–	92
2021 Q3	$6.54M	Sell	6,667 -1,793	-21%	-$2.24M	0.27%	64
2021 Q2	$12.6M	Sell	8,460 -429	-5%	-$935K	0.43%	55
2021 Q1	$23.9M	Buy	+8,889	New	+$17.6M	0.53%	41
2017 Q3	–	Sell	-2,201	Closed	-$1.22M	–	67
2017 Q2	$1.22M	Hold	2,201	–	–	0.2%	59
2017 Q1	$1.01M	Hold	2,201	–	–	0.15%	68
2016 Q4	$1.38M	Hold	2,201	–	–	0.19%	66
2016 Q3	$2.23M	Hold	2,201	–	–	0.25%	63
2016 Q2	$2.42M	Sell	2,201 -203	-8%	-$240K	0.34%	56
2016 Q1	$3.18M	Hold	2,404	–	–	0.48%	51
2015 Q4	$2.74M	Hold	2,404	–	–	0.33%	56
2015 Q3	$4.71M	Hold	2,404	–	–	0.75%	39
2015 Q2	$5.54M	Hold	2,404	–	–	0.74%	39
2015 Q1	$5.83M	Sell	2,404 -3	-0.1%	-$7.25K	0.9%	37
2014 Q4	$6.4M	Buy	+2,407	New	+$7.24M	0.99%	31

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Cormorant Asset Management's APTO Position: Q4 2021 in Review

Cormorant Asset Management sold out of Aptose Biosciences, Inc. (APTO) in Q4 2021, closing a stake of 6,667 shares — an estimated $6.54M sold.

Cormorant Asset Management first reported a position in APTO in Q4 2014 and held it in 14 quarters. The position peaked at $23.9M in Q1 2021. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.

Cormorant Asset Management reported no remaining Aptose Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
Cormorant Asset Management sold 6,667 Aptose Biosciences, Inc. shares in Q4 2021, an estimated $6.54M.
Cormorant Asset Management first reported a position in Aptose Biosciences, Inc. in Q4 2014 and held it in 14 quarters.
Cormorant Asset Management's Aptose Biosciences, Inc. position peaked at $23.9M in Q1 2021.
58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2021.

Based on Cormorant Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.